<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
58394-004-08
</NDCCode>
<PackageDescription>
10 CARTON in 1 TRAY (58394-004-08) > 1 KIT in 1 CARTON * 5 mL in 1 VIAL, SINGLE-DOSE (58394-104-08) * 1 mL in 1 SYRINGE (58394-019-02)
</PackageDescription>
<NDC11Code>
58394-0004-08
</NDC11Code>
<ProductNDC>
58394-004
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Neumega
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Oprelvekin
</NonProprietaryName>
<DosageFormName>
KIT
</DosageFormName>
<RouteName/>
<StartMarketingDate>
19971101
</StartMarketingDate>
<EndMarketingDate>
20170430
</EndMarketingDate>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA103694
</ApplicationNumber>
<LabelerName>
Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.
</LabelerName>
<SubstanceName/>
<StrengthNumber/>
<StrengthUnit/>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2017-05-02
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>